Manufacturer's investigation conclusion: the suspected arteriovenous thrombus could not be confirmed as no images or log files were provided by the account and the device was not returned for evaluation.The patient remains ongoing on heartmate 3 left ventricular assist system (lvas), serial number (b)(6).The relevant sections of the device history records for (b)(6), were reviewed and showed no deviations from manufacturing or quality assurance specifications.The heartmate 3 left ventricular assist system (lvas) instructions for use (ifu), rev.B, is currently available.Section 1 of the ifu, "introduction," lists potential adverse events, including venous thromboembolism and arterial non-central nervous system (cns) thromboembolism, which may be associated with the use of heartmate 3 lvas.Section 6 lists thromboembolism as a potential late post-implant complications that may be associated with the use of the heartmate 3 left ventricular assist system.Information regarding recommended anticoagulation therapy and international normalized ratio range is also provided in this section.No further information was provided.The manufacturer is closing the file on this event.
|